Preeclampsia (PE) is a leading cause of maternal and neonatal mortality and morbidity
worldwide, impacting the long‐term health of both mother and offspring. PE has long been …

Maternal obesity during pregnancy is rising and is associated with increased risk of
developing gestational diabetes mellitus (GDM), defined as glucose intolerance first …

Abstract Aims/Introduction Non‐coding ribonucleic acids (ncRNAs) have recently been
shown to be involved in various biological processes. However, most of these ncRNAs are …

Background: Gestational diabetes mellitus (GDM) is associated with increased fetal
adiposity, which may increase the risk of obesity in adulthood. The placenta has insulin …

Placental lipid metabolism is likely to be a determinant of placental transfer of fatty acids to
the fetus. Maternal conditions, such as obesity, have now been shown to regulate placental …

The incidence of type 2 diabetes is increasing every year and has become a serious public
health problem. In addition to genetic factors, environmental factors in early life development …

Objective Maternal obesity increases the incidence of excess adiposity in newborns,
resulting in lifelong diabetes risk. Elevated intrauterine fetal adiposity has been attributed to …

Maternal fatty acid and lipid metabolism undergoes changes during pregnancy to facilitate
fetal growth and development. Different types of fatty acids have different roles in …

Background and aims Placental lipid transport is altered in women with high prepregnancy
body mass index (pre-BMI) or gestational diabetes (GDM), which consequently affects foetal …

The discovery of insulin in 1921 was a major breakthrough in medicine and for therapy in
patients with diabetes. The dramatic rise in the prevalence of overweight and obesity has …